Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Esocheck/Esoguard
United Therapeutics Europe Ltd
Barrett Esophagus
1 trial -
Essential Amino Acid Enriched Whey Protein
United Therapeutics Europe Ltd
Whole-body Protein Balance
1 trial -
Estrogen-bazedoxifene
United Therapeutics Europe Ltd
Hand Osteoarthritis
1 trial -
Exclusive Enteral Nutrition Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
Exforge HCT® or Three Individual drug amlodipine + valsartan + hydrochlorothiazide
The University of Hong Kong
Intracerebral Hemorrhage
1 trial -
Experimental group
The First People's Hospital of Lianyungang
Overweight or Obesity
1 trial -
External beam radiotherapy
International Peace Maternity and Child Health Hospital
Squamous Cell Carcinoma of the Head and Neck
1 trial -
Facility HIVST
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Favipiravir
The First People's Hospital of Lianyungang
COVID-19
1 trial -
Febuxostat
The First People's Hospital of Lianyungang
Refractory Gout
1 trial -
Fei Re Qing Granules
The First People's Hospital of Lianyungang
Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
1 trial -
Ferric carboxymaltose
United Therapeutics Europe Ltd
Iron Deficiency
1 trial -
Fish Oil
Summit Therapeutics
Heart Disease
1 trial -
Fluorometholone
Hospital Authority, Hong Kong
Pterygium of the Conjunctiva and Cornea
1 trial -
Fluoxetine
United Therapeutics Europe Ltd
Depression - Major Depressive Disorder
1 trial -
Fluoxetine
The University of Hong Kong
Depression
1 trial -
Forced administration of furosemide
The First People's Hospital of Lianyungang
Cytoreductive Surgery
1 trial -
Fortified food rations
United Therapeutics Europe Ltd
Malnutrition
1 trial -
Fospropofol (Lusedra®) 6.5
Grace Therapeutics
Interstitial Cystitis
1 trial -
Fresh organic vegetables
United Therapeutics Europe Ltd
Diabetes Mellitus, Type 2
1 trial -
Fruit Bar
United Therapeutics Europe Ltd
Bioavailability
1 trial -
Fruquintinib and Everolimus
The First People's Hospital of Lianyungang
Renal Cell Carcinoma, Clear Cell, Somatic
1 trial -
G-CSF (Granulocyte colony-stimulating factor)
The First People's Hospital of Lianyungang
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources